Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

463 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expert Discussion: Predictive Markers.
Paradiso A, Codacci-Pisanelli G, Munzone E, Rugo HS, Heudel PE. Paradiso A, et al. Breast Care (Basel). 2021 Oct;16(5):552-557. doi: 10.1159/000519562. Epub 2021 Sep 29. Breast Care (Basel). 2021. PMID: 34720818 Free PMC article. No abstract available.
Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine.
Horgan D, Ciliberto G, Conte P, Curigliano G, Seijo L, Montuenga LM, Garassino M, Penault-Llorca F, Galli F, Ray-Coquard I, Querleu D, Riegman P, Kerr K, Van Poppel H, Bjartell A, Codacci-Pisanelli G, Koeva-Balabanova J, Paradiso A, Maravic Z, Fotaki V, Malats N, Bernini C, Buglioni S, Kent A, Munzone E, Belina I, Van Meerbeeck J, Duffy M, Jagielska B, Capoluongo E. Horgan D, et al. Among authors: paradiso a. Cancers (Basel). 2021 Feb 2;13(3):583. doi: 10.3390/cancers13030583. Cancers (Basel). 2021. PMID: 33540773 Free PMC article.
Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.
Horgan D, Ciliberto G, Conte P, Baldwin D, Seijo L, Montuenga LM, Paz-Ares L, Garassino M, Penault-Llorca F, Galli F, Ray-Coquard I, Querleu D, Capoluongo E, Banerjee S, Riegman P, Kerr K, Horbach B, Büttner R, Van Poppel H, Bjartell A, Codacci-Pisanelli G, Westphalen B, Calvo F, Koeva-Balabanova J, Hall S, Paradiso A, Kalra D, Cobbaert C, Varea Menendez R, Maravic Z, Fotaki V, Bennouna J, Cauchin E, Malats N, Gutiérrez-Ibarluzea I, Gannon B, Mastris K, Bernini C, Gallagher W, Buglioni S, Kent A, Munzone E, Belina I, Van Meerbeeck J, Duffy M, Sarnowska E, Jagielska B, Mee S, Curigliano G. Horgan D, et al. Among authors: paradiso a. Biomed Hub. 2020 Sep 14;5(3):182-223. doi: 10.1159/000511209. eCollection 2020 Sep-Dec. Biomed Hub. 2020. PMID: 33564664 Free PMC article.
Biomarkers: Where to Go from Here.
Paradiso A. Paradiso A. Breast Care (Basel). 2012 Feb;7(1):5-6. doi: 10.1159/000337179. Epub 2012 Feb 23. Breast Care (Basel). 2012. PMID: 22553465 Free PMC article. No abstract available.
Innovative Breast Cancer Biomarkers.
Paradiso A, Silvestrini R, Chiappetta G. Paradiso A, et al. Breast Care (Basel). 2010;5(2):60-61. doi: 10.1159/000309176. Epub 2010 Apr 13. Breast Care (Basel). 2010. PMID: 20847815 Free PMC article. No abstract available.
PARP Inhibitors in Breast Cancer: Why, How, and When?
Paradiso A, Andreopoulou E, Conte P, Eniu A, Saghatchian M. Paradiso A, et al. Breast Care (Basel). 2018 Jul;13(3):216-219. doi: 10.1159/000490746. Epub 2018 Jun 20. Breast Care (Basel). 2018. PMID: 30069183 Free PMC article. No abstract available.
Therapeutic Strategies in Triple-Negative Breast Cancer.
Paradiso A, Singer CF. Paradiso A, et al. Breast Care (Basel). 2017 Mar;12(1):6-7. doi: 10.1159/000460238. Epub 2017 Feb 28. Breast Care (Basel). 2017. PMID: 28611534 Free PMC article. No abstract available.
Biomarkers for Early Cancer Detection - Methodological Aspects.
Verderio P, Mangia A, Ciniselli CM, Tagliabue P, Paradiso A. Verderio P, et al. Among authors: paradiso a. Breast Care (Basel). 2010;5(2):62-65. doi: 10.1159/000303956. Epub 2010 Apr 21. Breast Care (Basel). 2010. PMID: 20847816 Free PMC article.
463 results